| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Oyler John is a Chief Executive Officer at BEIGF with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 85 sells.
Estimated insider holdings value: $583K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 55,175 | $251.84 | $13,895,479.20 | -23.0% | |
| Jul 8, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 53,914 | $199.12 | $10,735,455.18 | -28.7% | |
| Jul 1, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 5,251 | $191.85 | $1,007,390.65 | -63.9% | |
| Jun 24, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 39,732 | $185.90 | $7,385,983.11 | -11.7% | |
| Jun 10, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 900 | $175.07 | $157,563.00 | -100% | |
| May 1, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 4,635 | $141.43 | $655,537.37 | -38.4% | |
| Dec 17, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 62,259 | $160.62 | $10,000,099.87 | -33.0% | |
| Jul 8, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 3,106 | $126.87 | $394,055.49 | -49.3% | |
| May 1, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 2,824 | $125.18 | $353,504.52 | -65.7% | |
| Mar 6, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 25,499 | $151.73 | $3,868,938.48 | -56.9% |